MEMY Memory Pharmaceuticals Corp (MM)

MONTVALE, N.J., Nov. 14 /PRNewswire-FirstCall/ -- Memory Pharmaceuticals Corp. (NASDAQ:MEMY) today announced that Michael Smith, Chief Financial Officer and Head of Business Development, will provide a company update at the Lazard Capital Markets 5th Annual Healthcare Conference on Wednesday, November 19, 2008 at 3:30 p.m. EST at The St. Regis Hotel, in New York City. Interested parties may access the live webcast of the presentation by visiting the "Investors" section of Memory Pharmaceuticals' website at http://www.memorypharma.com/. Archived versions of the webcast will be available at the same location for one week following the presentation. About the Company Memory Pharmaceuticals Corp., a biopharmaceutical company, is focused on developing innovative drugs for the treatment of debilitating CNS disorders, many of which exhibit significant impairment of memory and other cognitive functions, including Alzheimer's disease and schizophrenia. For additional information, please visit our website at http://www.memorypharma.com/. DATASOURCE: Memory Pharmaceuticals Corp. CONTACT: Jzaneen Lalani, General Counsel, +1-201-802-7249, for Memory Pharmaceuticals Corp. Web Site: http://www.memorypharma.com/

Copyright